Status:
COMPLETED
Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Cerebral Amyloid Angiopathy
Siderosis
Eligibility:
All Genders
18+ years
Brief Summary
Cerebellar superficial siderosis (SS) has been recently reported to be present in about 10% of both hereditary (n=50) and sporadic (n=46) cerebral amyloid angiopathy (CAA) patients on 3T MRI using sus...
Eligibility Criteria
Inclusion
- CAA patients (according to the modified Boston criteria)
- with acute symptoms related to acute ICH, acute subarachnoid haemorrhage, or cortical SS
Exclusion
- Patients with recent trauma,
- Patients with anticoagulation treatment,
- Patients with pathological blood coagulation tests (activated partial thromboplastin time \[aPTT\] ratio=patient's aPTT/normal control aPTT\] \>1.2; or partial thromboplastin time \[PTT\] \<75%) or platelet count (\<100 x 109/L)
- Patients with inflammatory CAA
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT05394636
Start Date
June 1 2022
End Date
December 31 2022
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes
Nîmes, France, 30029